These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7038978)

  • 1. Potentiation of the activation of Glu-plasminogen by streptokinase and urokinase in the presence of fibrinogen degradation products.
    Takada A; Takada Y
    Thromb Res; 1982 Feb; 25(3):229-35. PubMed ID: 7038978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activation of Glu- and Lys-plasminogens by streptokinase: effects of fibrin, fibrinogen and their degradation products.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1985 Feb; 37(3):465-75. PubMed ID: 3992529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analyses of potentiation of plasminogen activation by streptokinase in the presence of fibrin or its degradation products.
    Takada Y; Takada A
    Haemostasis; 1987; 17(1-2):1-7. PubMed ID: 3596355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation of two isozymes of glu-plasminogen (I and II) by urokinase and streptokinase.
    Takada A; Takada Y
    Thromb Res; 1983 Jun; 30(6):633-42. PubMed ID: 6351345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1988 Jan; 49(2):253-63. PubMed ID: 3129817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Glu-plasminogen by urokinase in the presence of fibrinogen, fibrin, and SK-potentiator.
    Takada A; Takada Y
    Thromb Res; 1981 May; 22(4):497-501. PubMed ID: 6457416
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced activator activity of the mixture of streptokinase and a modified form of plasminogen (Lys-plasminogen) in the presence of fibrin: role of conformational change of plasminogen.
    Takada A; Takada Y; Sugawara Y
    Haemostasis; 1988; 18(2):106-12. PubMed ID: 3410360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glu-plasminogen I and II: their activation by urokinase and streptokinase in the presence of fibrin and fibrinogen.
    Takada Y; Makino Y; Takada A
    Thromb Res; 1985 Aug; 39(3):289-96. PubMed ID: 4049320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of coagulation on the activation of plasminogen by streptokinase and urokinase.
    Takada A; Urano T; Takada Y
    Thromb Haemost; 1979 Oct; 42(3):901-8. PubMed ID: 505405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN; Gurewich V
    J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
    Lipinski B; Gurewich V; Hyde E
    Thromb Diath Haemorrh; 1975 Sep; 34(1):351. PubMed ID: 1188799
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
    Lucas MA; Straight DL; Fretto LJ; McKee PA
    J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A; Takada Y
    Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator.
    Liu JN; Gurewich V
    Blood; 1993 Feb; 81(4):980-7. PubMed ID: 8428004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of plasminogen by tissue activator is increased specifically in the presence of certain soluble fibrin(ogen) fragments.
    Verheijen JH; Nieuwenhuizen W; Wijngaards G
    Thromb Res; 1982 Aug; 27(4):377-85. PubMed ID: 6890721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic analyses of the activation of Glu-plasminogen by urokinase in the presence of fibrin, fibrinogen or its degradation products.
    Watahiki Y; Takada Y; Takada A
    Thromb Res; 1987 Apr; 46(1):9-18. PubMed ID: 3590117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution of thrombi by tissue plasminogen activator, urokinase and streptokinase in an artificial circulating system.
    Mattsson C; Nyberg-Arrhenius V; Wallén P
    Thromb Res; 1981 Mar; 21(6):535-45. PubMed ID: 7022741
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of the streptokinase-catalyzed activation of human plasminogen by human fibrinogen and its plasminolysis products.
    Strickland DK; Morris JP; Castellino FJ
    Biochemistry; 1982 Feb; 21(4):721-8. PubMed ID: 7200372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptokinase-dependent potentiating factor (SK-potentiator) for plasminogen activation from human plasma: its identification as a fibrinogen degradation product.
    Hishikawa-Itoh Y; Sugie I; Kato H; Iwanaga S
    J Biochem; 1982 Oct; 92(4):1129-40. PubMed ID: 6890955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enhanced activation of Glu-plasminogen by urokinase in the presence of fibrin or des A fibrin as measured by the release of B beta peptide and FDP.
    Urano T; Takada Y; Takada A
    Thromb Res; 1984 Dec; 36(5):429-35. PubMed ID: 6084324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.